Share Price and Basic Stock Data
Last Updated: December 5, 2025, 6:22 pm
| PEG Ratio | 3.32 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
ICRA Ltd, a prominent player in the rating services industry, reported a current market capitalization of ₹5,932 Cr with a stock price of ₹6,136. The company’s revenue from operations has demonstrated a steady upward trajectory, rising from ₹343 Cr in FY 2022 to ₹403 Cr in FY 2023, and further projected to reach ₹446 Cr in FY 2024. For the trailing twelve months (TTM), revenue stood at ₹508 Cr. Quarterly sales figures reflect consistent growth, with Q1 FY 2025 recording ₹124 Cr, up from ₹109 Cr in Q4 FY 2023. This revenue growth trajectory aligns with the industry’s expansion, driven by increasing demand for credit ratings and risk assessments across sectors. The company’s operating profit margin (OPM) has remained robust, averaging around 32% during the recent quarters. Overall, ICRA’s revenue performance underscores its competitive positioning in the Indian rating services market, supported by rising business activity and a diversified client base.
Profitability and Efficiency Metrics
ICRA Ltd’s profitability metrics exhibit a commendable performance, with a net profit of ₹178 Cr reported for FY 2025, reflecting a growth from ₹137 Cr in FY 2023. The company’s return on equity (ROE) stood at 16.8%, while return on capital employed (ROCE) was recorded at 23.1%. These figures are indicative of effective management of shareholder funds and capital utilization. The interest coverage ratio (ICR) was notably high at 53.12x, highlighting ICRA’s strong ability to meet its interest obligations with ample operating income. The company’s OPM, although experiencing fluctuations, averaged around 32% in recent quarters, with a notable peak of 43% in Q4 FY 2025. This consistent profitability positions ICRA favorably within the sector. However, the declining net profit margins in certain quarters, such as 26% in Q3 FY 2024, suggest potential challenges in maintaining profitability amidst rising operational costs.
Balance Sheet Strength and Financial Ratios
ICRA Ltd’s balance sheet demonstrates considerable strength, with total assets reported at ₹1,292 Cr for FY 2025, supported by reserves of ₹1,078 Cr. The company maintains a low level of borrowings at ₹12 Cr, underscoring its financial prudence and low leverage. With a current ratio of 6.37x, ICRA exhibits strong liquidity, significantly above the typical sector range, indicating a robust ability to cover short-term liabilities. The price-to-book value (P/BV) ratio stood at 5.06x, suggesting that market investors are willing to pay a premium for ICRA’s earnings potential. Additionally, the company’s debt-to-equity ratio remains minimal, reflecting its conservative financing strategy. However, the high P/BV may also denote a potential overvaluation risk if earnings growth does not keep pace with market expectations. Overall, ICRA’s financial ratios indicate a solid foundation, essential for sustaining growth and navigating potential market fluctuations.
Shareholding Pattern and Investor Confidence
The shareholding pattern of ICRA Ltd indicates a stable equity structure, with promoters holding 51.86% of the company, thereby ensuring significant control and alignment with shareholder interests. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold 6.87% and 26.15%, respectively, reflecting robust institutional confidence in ICRA’s operational capabilities. The number of shareholders has steadily increased, reaching 21,818 by September 2025, which suggests growing investor interest. Despite fluctuations in FII participation, with a peak of 9.06% in December 2024, the overall institutional holding remains a positive indicator of market sentiment. However, the relatively high promoter holding could raise concerns regarding liquidity and the availability of shares for trading. Overall, the shareholding dynamics support a positive outlook for investor confidence, driven by ICRA’s strong performance and market position.
Outlook, Risks, and Final Insight
Looking ahead, ICRA Ltd is well-positioned to capitalize on the expanding demand for rating services in India, supported by its leading market position and strong financial metrics. However, the company faces potential risks, including fluctuations in operational costs, which could impact profitability, as evidenced by the varying OPM in recent quarters. Additionally, the high dependence on the domestic economy’s growth could pose challenges if macroeconomic conditions deteriorate. A potential scenario of sustained revenue growth could enhance ICRA’s market valuation, while a downturn in the economy may adversely affect its earnings. Overall, ICRA’s strengths, such as its strong balance sheet and profitability metrics, coupled with a stable shareholding structure, provide a solid foundation for future growth, despite the inherent risks associated with market volatility.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of ICRA Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| ICRA Ltd | 5,932 Cr. | 6,136 | 7,135/5,015 | 31.6 | 1,127 | 0.98 % | 23.1 % | 16.8 % | 10.0 |
| CARE Ratings Ltd | 4,618 Cr. | 1,542 | 1,965/1,052 | 30.2 | 288 | 1.17 % | 24.6 % | 18.0 % | 10.0 |
| Industry Average | 5,275.00 Cr | 3,839.00 | 30.90 | 707.50 | 1.08% | 23.85% | 17.40% | 10.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 93 | 99 | 103 | 109 | 103 | 105 | 115 | 124 | 115 | 126 | 121 | 136 | 124 |
| Expenses | 61 | 63 | 67 | 71 | 68 | 71 | 84 | 74 | 80 | 85 | 79 | 77 | 85 |
| Operating Profit | 32 | 36 | 36 | 38 | 35 | 34 | 30 | 50 | 35 | 41 | 42 | 59 | 40 |
| OPM % | 34% | 36% | 35% | 35% | 34% | 32% | 26% | 40% | 31% | 33% | 35% | 43% | 32% |
| Other Income | 7 | 13 | 15 | 16 | 18 | 16 | 17 | 24 | 18 | 20 | 19 | 21 | 24 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 7 | 2 | 0 | 1 | 1 | 2 |
| Depreciation | 2 | 2 | 3 | 3 | 2 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | 36 | 46 | 48 | 51 | 50 | 47 | 41 | 62 | 47 | 57 | 56 | 74 | 58 |
| Tax % | 41% | 19% | 18% | 24% | 18% | 32% | 20% | 24% | 24% | 35% | 24% | 24% | 27% |
| Net Profit | 22 | 37 | 39 | 39 | 41 | 32 | 32 | 47 | 36 | 37 | 42 | 56 | 43 |
| EPS in Rs | 22.02 | 38.06 | 40.29 | 39.76 | 41.77 | 32.92 | 33.31 | 48.56 | 36.80 | 38.05 | 43.55 | 57.75 | 43.97 |
Last Updated: August 1, 2025, 7:45 pm
Below is a detailed analysis of the quarterly data for ICRA Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 124.00 Cr.. The value appears to be declining and may need further review. It has decreased from 136.00 Cr. (Mar 2025) to 124.00 Cr., marking a decrease of 12.00 Cr..
- For Expenses, as of Jun 2025, the value is 85.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 77.00 Cr. (Mar 2025) to 85.00 Cr., marking an increase of 8.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Mar 2025) to 40.00 Cr., marking a decrease of 19.00 Cr..
- For OPM %, as of Jun 2025, the value is 32.00%. The value appears to be declining and may need further review. It has decreased from 43.00% (Mar 2025) to 32.00%, marking a decrease of 11.00%.
- For Other Income, as of Jun 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 3.00 Cr..
- For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2025) to 58.00 Cr., marking a decrease of 16.00 Cr..
- For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 27.00%, marking an increase of 3.00%.
- For Net Profit, as of Jun 2025, the value is 43.00 Cr.. The value appears to be declining and may need further review. It has decreased from 56.00 Cr. (Mar 2025) to 43.00 Cr., marking a decrease of 13.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 43.97. The value appears to be declining and may need further review. It has decreased from 57.75 (Mar 2025) to 43.97, marking a decrease of 13.78.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 6:02 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 283 | 322 | 341 | 333 | 309 | 328 | 321 | 301 | 343 | 403 | 446 | 498 | 508 |
| Expenses | 197 | 252 | 240 | 231 | 194 | 215 | 225 | 220 | 222 | 260 | 297 | 320 | 325 |
| Operating Profit | 86 | 70 | 101 | 102 | 115 | 113 | 96 | 81 | 121 | 143 | 149 | 178 | 182 |
| OPM % | 30% | 22% | 30% | 31% | 37% | 34% | 30% | 27% | 35% | 35% | 33% | 36% | 36% |
| Other Income | 19 | 42 | 27 | 39 | 49 | 45 | 48 | 43 | 41 | 50 | 75 | 77 | 84 |
| Interest | 1 | 2 | 1 | 0 | 0 | 0 | 2 | 2 | 2 | 1 | 10 | 5 | 4 |
| Depreciation | 6 | 10 | 10 | 9 | 8 | 6 | 10 | 10 | 8 | 10 | 13 | 16 | 17 |
| Profit before tax | 98 | 100 | 118 | 132 | 157 | 152 | 131 | 112 | 152 | 181 | 200 | 234 | 245 |
| Tax % | 30% | 35% | 35% | 33% | 35% | 30% | 26% | 26% | 25% | 25% | 24% | 27% | |
| Net Profit | 69 | 66 | 76 | 89 | 101 | 106 | 97 | 83 | 114 | 137 | 152 | 171 | 178 |
| EPS in Rs | 68.93 | 65.45 | 76.24 | 89.29 | 101.68 | 109.21 | 99.66 | 84.61 | 116.35 | 140.13 | 156.55 | 176.15 | 183.32 |
| Dividend Payout % | 33% | 37% | 33% | 30% | 29% | 27% | 27% | 32% | 24% | 93% | 64% | 34% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -4.35% | 15.15% | 17.11% | 13.48% | 4.95% | -8.49% | -14.43% | 37.35% | 20.18% | 10.95% | 12.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | 19.50% | 1.95% | -3.62% | -8.53% | -13.44% | -5.94% | 51.78% | -17.17% | -9.23% | 1.55% |
ICRA Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 9% |
| 3 Years: | 13% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 12% |
| 3 Years: | 15% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 15% |
| 3 Years: | 16% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 6:45 am
Balance Sheet
Last Updated: December 4, 2025, 1:24 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 378 | 419 | 466 | 539 | 645 | 631 | 692 | 748 | 834 | 941 | 967 | 1,044 | 1,078 |
| Borrowings | 16 | 10 | 0 | 0 | 0 | 0 | 0 | 17 | 14 | 13 | 13 | 13 | 12 |
| Other Liabilities | 109 | 144 | 151 | 111 | 116 | 128 | 144 | 121 | 121 | 138 | 195 | 225 | 265 |
| Total Liabilities | 513 | 583 | 627 | 660 | 771 | 769 | 846 | 896 | 978 | 1,101 | 1,184 | 1,292 | 1,364 |
| Fixed Assets | 89 | 91 | 92 | 37 | 36 | 34 | 54 | 46 | 46 | 47 | 91 | 90 | 90 |
| CWIP | 7 | 0 | 1 | 1 | 0 | 1 | 2 | 3 | 2 | 1 | 1 | 4 | 0 |
| Investments | 277 | 257 | 185 | 311 | 338 | 182 | 104 | 177 | 454 | 689 | 813 | 773 | 911 |
| Other Assets | 140 | 234 | 350 | 312 | 396 | 552 | 685 | 669 | 478 | 364 | 278 | 426 | 363 |
| Total Assets | 513 | 583 | 627 | 660 | 771 | 769 | 846 | 896 | 978 | 1,101 | 1,184 | 1,292 | 1,364 |
Below is a detailed analysis of the balance sheet data for ICRA Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,078.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,044.00 Cr. (Mar 2025) to 1,078.00 Cr., marking an increase of 34.00 Cr..
- For Borrowings, as of Sep 2025, the value is 12.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 13.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 265.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 225.00 Cr. (Mar 2025) to 265.00 Cr., marking an increase of 40.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,364.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,292.00 Cr. (Mar 2025) to 1,364.00 Cr., marking an increase of 72.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 90.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 90.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 4.00 Cr..
- For Investments, as of Sep 2025, the value is 911.00 Cr.. The value appears strong and on an upward trend. It has increased from 773.00 Cr. (Mar 2025) to 911.00 Cr., marking an increase of 138.00 Cr..
- For Other Assets, as of Sep 2025, the value is 363.00 Cr.. The value appears to be declining and may need further review. It has decreased from 426.00 Cr. (Mar 2025) to 363.00 Cr., marking a decrease of 63.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,364.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,292.00 Cr. (Mar 2025) to 1,364.00 Cr., marking an increase of 72.00 Cr..
Notably, the Reserves (1,078.00 Cr.) exceed the Borrowings (12.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 70.00 | 60.00 | 101.00 | 102.00 | 115.00 | 113.00 | 96.00 | 64.00 | 107.00 | 130.00 | 136.00 | 165.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 55 | 61 | 51 | 37 | 48 | 38 | 65 | 58 | 28 | 34 | 42 | 35 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 55 | 61 | 51 | 37 | 48 | 38 | 65 | 58 | 28 | 34 | 42 | 35 |
| Working Capital Days | -54 | -64 | -66 | -45 | -41 | -44 | -2 | -48 | -55 | -64 | -61 | -75 |
| ROCE % | 23% | 21% | 24% | 26% | 25% | 23% | 20% | 15% | 19% | 20% | 21% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Parag Parikh Flexi Cap Fund | 422,587 | 0.42 | 232.17 | 422,587 | 2025-04-22 17:25:32 | 0% |
| Aditya Birla Sun Life ELSS Tax Saver Fund | 282,810 | 1.04 | 155.37 | 282,810 | 2025-04-22 15:56:57 | 0% |
| Aditya Birla Sun Life MNC Fund - Div | 271,257 | 4.15 | 149.03 | 271,257 | 2025-04-22 15:56:57 | 0% |
| Aditya Birla Sun Life MNC Fund - Gr | 271,257 | 4.15 | 149.03 | 271,257 | 2025-04-22 15:56:57 | 0% |
| Canara Robeco Small Cap Fund | 168,320 | 0.96 | 92.47 | 168,320 | 2025-04-22 15:56:57 | 0% |
| Mahindra Manulife Small Cap Fund | 88,605 | 1.39 | 48.68 | 88,605 | 2025-04-22 17:25:32 | 0% |
| Sundaram Small Cap Fund | 85,868 | 1.54 | 47.18 | 85,868 | 2025-04-22 15:56:57 | 0% |
| Sundaram Diversified Equity Fund | 58,000 | 1.99 | 31.86 | 58,000 | 2025-04-22 17:25:32 | 0% |
| Sundaram Flexicap Fund | 46,000 | 1.22 | 25.27 | 46,000 | 2025-04-22 15:56:57 | 0% |
| Sundaram Focused Fund | 43,000 | 2.38 | 23.62 | 43,000 | 2025-04-22 15:56:57 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 176.73 | 157.07 | 140.59 | 116.74 | 84.89 |
| Diluted EPS (Rs.) | 176.50 | 156.99 | 140.59 | 116.74 | 84.89 |
| Cash EPS (Rs.) | 194.38 | 171.69 | 151.85 | 125.73 | 95.95 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1091.29 | 1016.43 | 989.44 | 878.36 | 788.52 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1091.29 | 1016.43 | 989.44 | 878.36 | 788.52 |
| Revenue From Operations / Share (Rs.) | 516.02 | 462.24 | 417.80 | 355.19 | 311.94 |
| PBDIT / Share (Rs.) | 264.39 | 231.82 | 199.41 | 167.29 | 128.46 |
| PBIT / Share (Rs.) | 247.40 | 217.87 | 189.23 | 159.20 | 118.18 |
| PBT / Share (Rs.) | 242.43 | 207.08 | 187.77 | 157.58 | 116.05 |
| Net Profit / Share (Rs.) | 177.39 | 157.74 | 141.67 | 117.64 | 85.67 |
| NP After MI And SOA / Share (Rs.) | 176.15 | 156.56 | 140.12 | 116.35 | 84.61 |
| PBDIT Margin (%) | 51.23 | 50.15 | 47.72 | 47.09 | 41.18 |
| PBIT Margin (%) | 47.94 | 47.13 | 45.29 | 44.82 | 37.88 |
| PBT Margin (%) | 46.98 | 44.80 | 44.94 | 44.36 | 37.20 |
| Net Profit Margin (%) | 34.37 | 34.12 | 33.90 | 33.11 | 27.46 |
| NP After MI And SOA Margin (%) | 34.13 | 33.86 | 33.53 | 32.75 | 27.12 |
| Return on Networth / Equity (%) | 16.14 | 15.47 | 14.23 | 13.31 | 10.77 |
| Return on Capital Employeed (%) | 21.37 | 20.30 | 18.84 | 17.80 | 14.62 |
| Return On Assets (%) | 13.13 | 12.72 | 12.28 | 11.47 | 9.11 |
| Asset Turnover Ratio (%) | 0.40 | 0.38 | 0.24 | 0.23 | 0.23 |
| Current Ratio (X) | 6.37 | 4.32 | 4.29 | 3.77 | 4.26 |
| Quick Ratio (X) | 6.37 | 4.32 | 4.29 | 3.77 | 4.26 |
| Dividend Payout Ratio (NP) (%) | 56.58 | 82.76 | 19.91 | 23.12 | 31.80 |
| Dividend Payout Ratio (CP) (%) | 51.60 | 75.99 | 18.56 | 21.62 | 28.36 |
| Earning Retention Ratio (%) | 43.42 | 17.24 | 80.09 | 76.88 | 68.20 |
| Cash Earning Retention Ratio (%) | 48.40 | 24.01 | 81.44 | 78.38 | 71.64 |
| Interest Coverage Ratio (X) | 53.12 | 21.50 | 136.25 | 103.41 | 60.27 |
| Interest Coverage Ratio (Post Tax) (X) | 36.64 | 15.63 | 97.80 | 73.71 | 41.19 |
| Enterprise Value (Cr.) | 5054.70 | 5105.59 | 4025.55 | 3803.03 | 2773.34 |
| EV / Net Operating Revenue (X) | 10.15 | 11.44 | 9.98 | 11.09 | 9.21 |
| EV / EBITDA (X) | 19.81 | 22.82 | 20.92 | 23.55 | 22.37 |
| MarketCap / Net Operating Revenue (X) | 10.70 | 11.78 | 10.57 | 11.99 | 10.53 |
| Retention Ratios (%) | 43.41 | 17.23 | 80.08 | 76.87 | 68.19 |
| Price / BV (X) | 5.06 | 5.38 | 4.49 | 4.87 | 4.18 |
| Price / Net Operating Revenue (X) | 10.70 | 11.78 | 10.57 | 11.99 | 10.53 |
| EarningsYield | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 |
After reviewing the key financial ratios for ICRA Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 176.73. This value is within the healthy range. It has increased from 157.07 (Mar 24) to 176.73, marking an increase of 19.66.
- For Diluted EPS (Rs.), as of Mar 25, the value is 176.50. This value is within the healthy range. It has increased from 156.99 (Mar 24) to 176.50, marking an increase of 19.51.
- For Cash EPS (Rs.), as of Mar 25, the value is 194.38. This value is within the healthy range. It has increased from 171.69 (Mar 24) to 194.38, marking an increase of 22.69.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,091.29. It has increased from 1,016.43 (Mar 24) to 1,091.29, marking an increase of 74.86.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,091.29. It has increased from 1,016.43 (Mar 24) to 1,091.29, marking an increase of 74.86.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 516.02. It has increased from 462.24 (Mar 24) to 516.02, marking an increase of 53.78.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 264.39. This value is within the healthy range. It has increased from 231.82 (Mar 24) to 264.39, marking an increase of 32.57.
- For PBIT / Share (Rs.), as of Mar 25, the value is 247.40. This value is within the healthy range. It has increased from 217.87 (Mar 24) to 247.40, marking an increase of 29.53.
- For PBT / Share (Rs.), as of Mar 25, the value is 242.43. This value is within the healthy range. It has increased from 207.08 (Mar 24) to 242.43, marking an increase of 35.35.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 177.39. This value is within the healthy range. It has increased from 157.74 (Mar 24) to 177.39, marking an increase of 19.65.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 176.15. This value is within the healthy range. It has increased from 156.56 (Mar 24) to 176.15, marking an increase of 19.59.
- For PBDIT Margin (%), as of Mar 25, the value is 51.23. This value is within the healthy range. It has increased from 50.15 (Mar 24) to 51.23, marking an increase of 1.08.
- For PBIT Margin (%), as of Mar 25, the value is 47.94. This value exceeds the healthy maximum of 20. It has increased from 47.13 (Mar 24) to 47.94, marking an increase of 0.81.
- For PBT Margin (%), as of Mar 25, the value is 46.98. This value is within the healthy range. It has increased from 44.80 (Mar 24) to 46.98, marking an increase of 2.18.
- For Net Profit Margin (%), as of Mar 25, the value is 34.37. This value exceeds the healthy maximum of 10. It has increased from 34.12 (Mar 24) to 34.37, marking an increase of 0.25.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 34.13. This value exceeds the healthy maximum of 20. It has increased from 33.86 (Mar 24) to 34.13, marking an increase of 0.27.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.14. This value is within the healthy range. It has increased from 15.47 (Mar 24) to 16.14, marking an increase of 0.67.
- For Return on Capital Employeed (%), as of Mar 25, the value is 21.37. This value is within the healthy range. It has increased from 20.30 (Mar 24) to 21.37, marking an increase of 1.07.
- For Return On Assets (%), as of Mar 25, the value is 13.13. This value is within the healthy range. It has increased from 12.72 (Mar 24) to 13.13, marking an increase of 0.41.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.40. It has increased from 0.38 (Mar 24) to 0.40, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 6.37. This value exceeds the healthy maximum of 3. It has increased from 4.32 (Mar 24) to 6.37, marking an increase of 2.05.
- For Quick Ratio (X), as of Mar 25, the value is 6.37. This value exceeds the healthy maximum of 2. It has increased from 4.32 (Mar 24) to 6.37, marking an increase of 2.05.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 56.58. This value exceeds the healthy maximum of 50. It has decreased from 82.76 (Mar 24) to 56.58, marking a decrease of 26.18.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 51.60. This value exceeds the healthy maximum of 50. It has decreased from 75.99 (Mar 24) to 51.60, marking a decrease of 24.39.
- For Earning Retention Ratio (%), as of Mar 25, the value is 43.42. This value is within the healthy range. It has increased from 17.24 (Mar 24) to 43.42, marking an increase of 26.18.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 48.40. This value is within the healthy range. It has increased from 24.01 (Mar 24) to 48.40, marking an increase of 24.39.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 53.12. This value is within the healthy range. It has increased from 21.50 (Mar 24) to 53.12, marking an increase of 31.62.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 36.64. This value is within the healthy range. It has increased from 15.63 (Mar 24) to 36.64, marking an increase of 21.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 5,054.70. It has decreased from 5,105.59 (Mar 24) to 5,054.70, marking a decrease of 50.89.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 10.15. This value exceeds the healthy maximum of 3. It has decreased from 11.44 (Mar 24) to 10.15, marking a decrease of 1.29.
- For EV / EBITDA (X), as of Mar 25, the value is 19.81. This value exceeds the healthy maximum of 15. It has decreased from 22.82 (Mar 24) to 19.81, marking a decrease of 3.01.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 10.70. This value exceeds the healthy maximum of 3. It has decreased from 11.78 (Mar 24) to 10.70, marking a decrease of 1.08.
- For Retention Ratios (%), as of Mar 25, the value is 43.41. This value is within the healthy range. It has increased from 17.23 (Mar 24) to 43.41, marking an increase of 26.18.
- For Price / BV (X), as of Mar 25, the value is 5.06. This value exceeds the healthy maximum of 3. It has decreased from 5.38 (Mar 24) to 5.06, marking a decrease of 0.32.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 10.70. This value exceeds the healthy maximum of 3. It has decreased from 11.78 (Mar 24) to 10.70, marking a decrease of 1.08.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in ICRA Ltd:
- Net Profit Margin: 34.37%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21.37% (Industry Average ROCE: 23.85%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.14% (Industry Average ROE: 17.4%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 36.64
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 6.37
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 31.6 (Industry average Stock P/E: 30.9)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 34.37%
About the Company - ICRA Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Rating Services | B-710, Statesman House, 148, Barakhamba Road, New Delhi Delhi 110001 | investors@icraindia.com http://www.icra.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. D N Ghosh | Chairman Emeritus |
| Mr. Arun Duggal | Chairman & Ind.Dire (Non-Exe) |
| Mr. Ramnath Krishnan | Managing Director & Group CEO |
| Ms. Wendy Huay Huay Cheong | Non Exe.Non Ind.Director |
| Ms. Shivani Priya Mohini Kak | Non Exe.Non Ind.Director |
| Mr. Stephen Arthur Long | Non Exe.Non Ind.Director |
| Mr. Michael Foley | Non Exe.Non Ind.Director |
| Ms. Ranjana Agarwal | Independent Director |
| Ms. Radhika Vijay Haribhakti | Independent Director |
ICRA Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹5,385.65 |
| Previous Day | ₹5,305.05 |
FAQ
What is the intrinsic value of ICRA Ltd?
ICRA Ltd's intrinsic value (as of 06 December 2025) is 4833.32 which is 21.23% lower the current market price of 6,136.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 5,932 Cr. market cap, FY2025-2026 high/low of 7,135/5,015, reserves of ₹1,078 Cr, and liabilities of 1,364 Cr.
What is the Market Cap of ICRA Ltd?
The Market Cap of ICRA Ltd is 5,932 Cr..
What is the current Stock Price of ICRA Ltd as on 06 December 2025?
The current stock price of ICRA Ltd as on 06 December 2025 is 6,136.
What is the High / Low of ICRA Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of ICRA Ltd stocks is 7,135/5,015.
What is the Stock P/E of ICRA Ltd?
The Stock P/E of ICRA Ltd is 31.6.
What is the Book Value of ICRA Ltd?
The Book Value of ICRA Ltd is 1,127.
What is the Dividend Yield of ICRA Ltd?
The Dividend Yield of ICRA Ltd is 0.98 %.
What is the ROCE of ICRA Ltd?
The ROCE of ICRA Ltd is 23.1 %.
What is the ROE of ICRA Ltd?
The ROE of ICRA Ltd is 16.8 %.
What is the Face Value of ICRA Ltd?
The Face Value of ICRA Ltd is 10.0.